Recall Enhancement Through Treatment With Atomoxetine in MS (RETAIN-MS)
Clinical trial NCT03091400 · COMPLETED
Trial details
- NCT number
- NCT03091400
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-16
- Primary completion
- 2018-06-11
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.